Skip to content
SHORLA ONCOLOGY
  • About Us
  • Our Team
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • SH-105
    • SH-110
    • SH-111
    • SH-114
  • Careers
  • News
    • Company Updates
    • Media
  • Contact

Shorla Oncology at Bio CEO & Investor conference, New York 2022

March 4th 2022February 14th 2022

Read More

Shorla Oncology at Euronext IPO ready programme, Dublin 2022

March 7th 2022February 14th 2022

Read More

3 Keys To A Successful Biotech Launch

February 28th 2022February 1st 2022

Read More

Shorla: making women’s and children’s cancer drugs more accessible

March 7th 2022December 22nd 2021

Read More

Shorla Oncology at ASH, Atlanta, Georgia 2021

March 7th 2022December 2nd 2021

Read More

CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in Boston

March 7th 2022November 4th 2021

Read More

Shorla Oncology at CPhI Worldwide in Milan

March 7th 2022November 1st 2021

Read More

Shorla Oncology at Asembia Specialty Pharmacy Summit

March 7th 2022October 22nd 2021

Read More

Shorla recently welcomed the Minister of State for Business, Employment and Retail, Damien English to the Clonmel office

March 7th 2022September 24th 2021

Read More

Older posts
Page1 Page2 … Page5

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

Shorla Pharma Ltd trading as Shorla Oncology®

 

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2022

© 2023 SHORLA ONCOLOGY • Built with GeneratePress
  • About Us
  • Our Team
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • SH-105
    • SH-110
    • SH-111
    • SH-114
  • Careers
  • News
    • Company Updates
    • Media
  • Contact